Antares Pharma, Inc. (ATRS)

Operating Expenses

$112.69M

TTM · Period ending: · USD

ATRS logo

ATRS Operating Expenses

Latest reported$112.69M
ATRS TTM Operating Expenses ($3.90M → $112.69M)
High-resolution chart · PNG

ATRS operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
112,689,000
107,326,000
84,771,000
78,610,000
73,724,000
72,880,000
72,150,000
73,762,000
74,478,000
72,397,000
69,054,000
61,744,000
55,276,000
49,090,000
45,138,781
44,676,091
44,082,464
43,500,000
44,274,725
44,380,902
44,824,069
47,521,740
48,115,041
48,287,110
48,498,332
46,662,396
47,362,383
46,845,646
48,959,742
50,378,265
47,365,756
45,001,339
39,201,013
32,271,587
31,108,127
28,144,367
25,440,203
24,506,605
19,108,164
16,578,010
15,540,621
14,098,087
14,277,145
14,606,160
14,466,204
14,571,946
14,413,691
14,147,460
13,644,560
13,864,872
14,332,706
14,710,624
15,609,044
15,839,095
15,319,950
14,869,171
14,304,628
13,060,562
12,565,628
11,236,174
10,794,827
10,595,958
10,099,805
10,195,705
9,770,391
9,677,175
10,223,534
10,662,115
10,093,310
9,748,320
9,938,246
10,195,116
10,292,229
10,413,001
12,068,115
11,547,230
11,841,471
11,684,377
10,320,090
10,394,048
10,409,562
10,184,646
8,731,690
7,581,407
6,291,098
5,352,558
4,061,985
4,228,887
4,410,794
4,907,372
6,544,673
6,844,673
7,044,673
7,044,673
6,035,894
5,835,894
5,835,894
5,835,894
5,901,221
5,701,221
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.